Semaglutide
Pharmaceutical-grade semaglutide lyophilised powder. The most widely prescribed GLP-1 receptor agonist for weight management and glycaemic control.
Request a Quote
Pricing available for qualified medical professionals, clinics, and distributors.
Enquire NowDownload MonographView FAQMechanism of Action
Semaglutide is a GLP-1 receptor agonist with 94% sequence homology to native GLP-1. A C-18 fatty diacid chain enables non-covalent albumin binding, extending the half-life to ~7 days. It acts on hypothalamic and brainstem GLP-1 receptors to reduce appetite, increase satiety, and slow gastric emptying. Semaglutide also improves β-cell function and insulin sensitivity.
Clinical Benefits
- Potent GLP-1 receptor agonism
- Extended half-life enabling weekly dosing
- Demonstrated 15–17% mean body weight reduction in trials
- Supports glycaemic control and cardiovascular health
Specifications
Storage & Handling
- Store at 2–8°C
- Protect from light
- Reconstituted: use per clinical protocol
For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.